BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -20.56% | -29.86% | -3.65% | -16.27% | -1.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.56% | -29.86% | -3.65% | -16.27% | -1.10% |
| Cost of Revenue | -12.17% | -13.87% | -13.34% | -20.77% | -27.07% |
| Gross Profit | -28.28% | -95.97% | 985.39% | 100.23% | 46.98% |
| SG&A Expenses | 7.48% | -13.38% | -16.99% | -11.12% | 1.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.83% | -13.81% | -13.81% | -19.59% | -14.52% |
| Operating Income | -1,846.95% | -205.75% | 77.45% | 54.15% | 94.06% |
| Income Before Tax | -8,256.27% | -180.38% | 88.67% | 63.15% | 101.45% |
| Income Tax Expenses | 619.35% | -180.35% | 88.66% | 63.12% | 119.32% |
| Earnings from Continuing Operations | -3,033.30% | -180.40% | 88.67% | 63.16% | 91.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3,033.30% | -180.40% | 88.67% | 63.16% | 91.78% |
| EBIT | -1,846.95% | -205.75% | 77.45% | 54.15% | 94.06% |
| EBITDA | -494.62% | -139.16% | 112.75% | 109.28% | 133.02% |
| EPS Basic | -3,033.77% | -180.40% | 88.67% | 63.15% | 91.78% |
| Normalized Basic EPS | -8,246.74% | -180.39% | 88.67% | 63.14% | 101.45% |
| EPS Diluted | -2,981.82% | -180.40% | 88.71% | 63.16% | 91.67% |
| Normalized Diluted EPS | -8,246.74% | -180.39% | 88.67% | 63.14% | 101.45% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | 0.00% |
| Payout Ratio | -- | -- | -- | -- | -- |